Definitive radiation therapy for stage i non-small-cell lung carcinoma: institutional experience with contemporary conformal planning

Clinical Lung Cancer

Volumn 10, Issue 6, 2009, Pages 433-437

  Sandhu, Ajay P ^a   Messer, Karen ^a   Fuster, Mark M ^b   Ahmad, Ehatsham ^a   Pu, Minya ^a   Bazhenova, Lyudmilla ^a   Rose, Maryanne ^a   Seagren, Stephen ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Failure free survival; Hypofractionation; Local control; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; HUMAN; INOPERABLE CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; RADIATION DOSE; CANCER STAGING; FOLLOW UP; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; RADIATION INJURY; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT FAILURE;

EID: 74949084685     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLC.2009.n.081     Document Type: Article

References (29)

1. Shields TW. Surgical therapy for carcinoma of the lung. Clin Chest Med 1993; 14:121-147
2. Mountain CF. A new international staging system for lung cancer. Chest 1986; 89:225S-33S.
3. Damhuis R, Coonar A, Plaisier P, et al. A case-mix model for monitoring of postoperative mortality after surgery for lung cancer. Lung Cancer 2006; 51:123-129
4. Alexiou C, Beggs D, Onyeaka P, et al. Pneumonectomy for stage I (T1N0 and T2N0) nonsmall cell lung cancer has potent, adverse impact on survival. Ann Thorac Surg 2003; 76:1023-1028
5. Wisnivesky JP, Bonomi M, Henschke C, et al. Radiation therapy for the treatment of unresected stage I-II non-small cell lung cancer. Chest 2005; 128:1461-1467 (Pubitemid 41324433)
6. Raz DJ, Zell JA, Ou SH, et al. Natural history of stage I non-small cell lung cancer: implications for early detection. Chest 2007; 132:193-199
7. Coy P, Kennelly GM. The role of curative radiotherapy in the treatment of lung cancer. Cancer 1980; 45:698-702.
8. Armstrong JG, Minsky BD. Radiation therapy for medically inoperable stage I and II non-small cell lung cancer. Cancer Treat Rev 1989; 16:247-255
9. Haffty BG, Goldberg NB, Gerstley J, et al. Results of radical radiation therapy in clinical stage I, technically inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1988; 15:69-73.
10. Fang LC, Komaki R, Allen P, et al. Comparison of outcomes for patients with medically inoperable stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy. Int J Radiat Oncol Biol Phys 2006; 66:108-116 (Pubitemid 44175656)
11. Kong F-M, Ten Haken R, Schipper M, et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/ unresectable nonsmallcell lung cancer: long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 2005; 63:324-333
12. Pintilie M. Competing Risks: A Practical Perspective. Chichester: John Wiley & Sons, Ltd; 2006.
13. Brookmeyer R, Crowley J. A confidence interval for the median survival time. Biometrics 1982; 38:29-41.
14. Dosoretz DE, Katin MJ, Blitzer PH, et al. Medically inoperable lung carcinoma. The role of radiation therapy. Semin Radiat Oncol 1996; 6:98-104.
15. Sibley GS, Jamieson TA, Marks LB, et al. Radiotherapy alone for medically inoperable stage I non-small cell carcinoma: The Duke experience. Int J Radiat Oncol Biol Phys 1998; 40:149-154
16. Werner-Wasik M, Swann RS, Bradley J, et al. Increasing tumor volume is predictive of poor overall and progression-free survival: secondary analysis of the RTOG group 93-11 phase I/II radiation dose escalation study in patients with inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008; 70:385-390
17. Curran WJ, Moldofsky PJ, Solin LJ, et al. Analysis of influence of elective nodal irradiation on postirradiation pulmonary function. Cancer 1990; 65:2488-2493
18. Williams TE, Thomas CR Jr, Turrisi AT III, et al. Counterpoint: better radiation treatment of non-small cell lung cancer using new techniques without elective nodal irradiation. Semin Radiat Oncol 2000; 10:315-323
19. Slotman BJ, Antonisse IE, Njo KH, et al. Limited field irradiation in early stage (T1-2N0) non-small cell lung cancer. Radiother Oncol 1996; 41:41-44
20. Robertson JM, Ten Haken RK, Hazuka MB, et al. Dose escalation for non-small cell lung cancer using conformal radiation therapy. Int J Radiat Oncol Biol Phys 1997; 37:1079-1085
21. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg 1995; 60:615-623
22. Reed CE, Harpole DH, Posther KE, et al. Results of the American College of Surgeons Oncology Group Z0050 trial: The utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg 2003; 126:1943-1951
23. Brock J, Ashley S, Bedford J, et al. Review of hypofractionated small volume radiotherapy for early-stage non-small cell lung cancer. Clin Oncol (R Coll Radiol) 2008; 20:666-676
24. Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005; 63:1427-1431
25. Timmerman R, Papiez L, McGarry R, et al. Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer patients. Chest 2003; 124:1946-1955
26. Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004; 101:1623-1631
27. Fritz P, Kraus HJ, Blaschke T, et al. Stereotactic, high single-dose irradiation of stage I non-small cell lung cancer (NSCLC) using four-dimensional CT scans for treatment planning. Lung Cancer 2008; 60:193-199
28. Xia T, Li H, Sun Q, et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006; 66:117-125
29. Nyman J, Johansson KA, Hulten U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer-mature results for medically inoperable patients. Lung Cancer 2006; 51:97-103.